Literature DB >> 16011678

Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.

A James O'Malley1, Sharon-Lise T Normand.   

Abstract

While several new methods that account for noncompliance or missing data in randomized trials have been proposed, the dual effects of noncompliance and nonresponse are rarely dealt with simultaneously. We construct a maximum likelihood estimator (MLE) of the causal effect of treatment assignment for a two-armed randomized trial assuming all-or-none treatment noncompliance and allowing for subsequent nonresponse. The EM algorithm is used for parameter estimation. Our likelihood procedure relies on a latent compliance state covariate that describes the behavior of a subject under all possible treatment assignments and characterizes the missing data mechanism as in Frangakis and Rubin (1999, Biometrika 86, 365-379). Using simulated data, we show that the MLE for normal outcomes compares favorably to the method-of-moments (MOM) and the standard intention-to-treat (ITT) estimators under (1) both normal and non-normal data, and (2) departures from the latent ignorability and compound exclusion restriction assumptions. We illustrate methods using data from a trial to compare the efficacy of two antipsychotics for adults with refractory schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16011678     DOI: 10.1111/j.1541-0420.2005.040313.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  13 in total

1.  Bias Mechanisms in Intention-to-Treat Analysis With Data Subject to Treatment Noncompliance and Missing Outcomes.

Authors:  Booil Jo
Journal:  J Educ Behav Stat       Date:  2007-01-01

2.  Telephone interventions for co-morbid insomnia and osteoarthritis pain: The OsteoArthritis and Therapy for Sleep (OATS) randomized trial design.

Authors:  Susan M McCurry; Michael Von Korff; Charles M Morin; Amy Cunningham; Kenneth C Pike; Manu Thakral; Robert Wellman; Kai Yeung; Weiwei Zhu; Michael V Vitiello
Journal:  Contemp Clin Trials       Date:  2019-10-13       Impact factor: 2.226

3.  Commentary on Bryan Dowd's paper "separated at birth: statisticians, social scientists, and causality in health services research".

Authors:  A James O'Malley
Journal:  Health Serv Res       Date:  2011-01-28       Impact factor: 3.402

Review 4.  Handling missing data in randomized experiments with noncompliance.

Authors:  Booil Jo; Elizabeth M Ginexi; Nicholas S Ialongo
Journal:  Prev Sci       Date:  2010-12

5.  A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial.

Authors:  Lily L Altstein; Gang Li; Robert M Elashoff
Journal:  Stat Med       Date:  2010-11-30       Impact factor: 2.373

6.  Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model.

Authors:  L Altstein; G Li
Journal:  Biometrics       Date:  2013-02-05       Impact factor: 2.571

7.  Using an instrumental variable to test for unmeasured confounding.

Authors:  Zijian Guo; Jing Cheng; Scott A Lorch; Dylan S Small
Journal:  Stat Med       Date:  2014-06-15       Impact factor: 2.373

8.  Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.

Authors:  Shôn W Lewis; Thomas R E Barnes; Linda Davies; Robin M Murray; Graham Dunn; Karen P Hayhurst; Alison Markwick; Helen Lloyd; Peter B Jones
Journal:  Schizophr Bull       Date:  2006-03-15       Impact factor: 9.306

9.  Estimating intervention effects of prevention programs: accounting for noncompliance.

Authors:  Elizabeth A Stuart; Deborah F Perry; Huynh-Nhu Le; Nicholas S Ialongo
Journal:  Prev Sci       Date:  2008-10-09

10.  Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data.

Authors:  Hua Chen; Zhi Geng; Xiao-Hua Zhou
Journal:  Biometrics       Date:  2008-08-28       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.